Investment
Features
FeesSafety
Academy
More
Pluang+

Compare T-Mobile Us Inc (TMUS) vs Zoetis Inc (ZTS) Price & Performance

T-Mobile Us IncTrade
Zoetis IncTrade

Price performance (Past 24H)

Key statistics

T-Mobile Us Inc vs Zoetis Inc — how do they compare? T-Mobile Us Inc trades at $190.13 (market cap $211.72B), while Zoetis Inc trades at $75.47 (market cap $31.95B). The key difference: T-Mobile Us Inc is far larger — about 6.6× Zoetis Inc's market cap, and Zoetis Inc pays the higher dividend (2.78%). Which is the better fit depends on your goals.

TMUSZTS
Market Cap
$211.72B$31.95B
Sector
MediaHealth
52-Week High
$259.01$156.76
52-Week Low
$167.65$71.91
Enterprise Value
$329.42B$39.24B
Dividend Yield
2.09%2.78%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

T-Mobile Us Inc

No Aura AI signal available yet.

Zoetis Inc

Zoetis (ZTS) trades at $75.33, down 1.61% amid mixed technical signals and ongoing securities litigation. The stock shows strong fundamentals with a 28.03% net margin and 67.75% ROE, supported by consistent revenue growth from $8.1B in 2022 to $9.47B in 2025. Recent earnings beat expectations in Q3 and Q4 2025 but missed in Q1 2026, with Q2 results pending. Analyst consensus remains positive with a $101.43 price target, though technical indicators show neutral momentum near key support at $75.

The outlook for ZTS is cautiously optimistic given robust profitability and analyst support, but significant legal overhangs and recent earnings volatility present near-term risks. Long-term growth in animal health markets offers upside, yet investors should monitor litigation developments and Q2 earnings for directional cues.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About T-Mobile Us Inc

Deutsche Telekom merged its T-Mobile USA unit with prepaid specialist MetroPCS in 2013, creating T-Mobile Us. Following the merger, the firm provided nationwide service in major markets but spottier coverage elsewhere. T-Mobile spent aggressively on low-frequency spectrum, well suited to broad coverage, and has substantially expanded its geographic footprint. This expansion, coupled with aggressive marketing and innovative offerings, produced rapid customer growth. With the Sprint acquisition, the firm's scale now roughly matches its larger rivals: T-Mobile now serves 71 million postpaid and 21 million prepaid phone customers, equal to around 30% of the U.S. retail wireless market. In addition, the firm provides wholesale service to resellers.

Read more on TMUS

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Read more on ZTS